Erectile dysfunction: A marker for myocardial perfusion impairment?

Arquivos Brasileiros de Cardiologia

Volumn 85, Issue 4, 2005, Pages

  Ortiz, Juarez ^a,b   Ortiz, Sergio Tranchesi ^a   Monaco, Claudia Gianini ^a   Yamashita, Cristina Harumi ^a   Mendes Moreira, Miriam Cássia ^a   Monaco, Carlos Alberto F ^a  

^a OMNI CCNI Medicina Diagnóstica   (Brazil)

^b OMNI CCNI   (Brazil)

Author keywords

Atherosclerosis; Coronary artery disease; Erectile dysfunction; Myocardial perfusion; Nuclear medicine; Risk factors

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGE; AGED; ARTICLE; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE MARKER; ERECTILE DYSFUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE WALL MOTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART MUSCLE PERFUSION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; IMAGING; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL DISEASE; PHARMACOLOGIC STRESS TESTING; PHYSICAL STRESS; PREVALENCE; PROSPECTIVE STUDY; QUESTIONNAIRE; REST; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSLUMINAL CORONARY ANGIOPLASTY; BRAZIL; CORONARY ARTERY ATHEROSCLEROSIS; EPIDEMIOLOGY; FEMALE; IMPOTENCE; MIDDLE AGED; SCINTISCANNING;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BRAZIL; CORONARY ARTERIOSCLEROSIS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; HYPERTENSION; IMPOTENCE; MALE; MIDDLE AGED; QUESTIONNAIRES; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI;

EID: 31144436472     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. th ed. Philadelphia: WB Saundesrs Company, 1988.
2. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281:537-44.
3. O'Kane PD, Jackson G. Erectile dysfunction: is there silent obstructive coronary artery disease? Int J Clin Pract 2001;55:219-20.
4. Gazzaruso C, Giordanetti S, De Amici E, et al. Relationship between erectile dysfunction and silent ischemia in apparently uncomplicated type 2 diabetic patients. Circulation 2004;110:22-26.
5. Conti CR, Pepine CJ, Sweeney M. Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease. Am J Cardiol 1999;83:29C-34C.
6. El-Sakka A, Morsy AM. Screening for ischemic heart disease in patients with erectile dysfunction: role of penile Doppler ultrasonography. Urology 2004;64:346-50.
7. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachutts Male Aging Study. J Urol 1994;151:54-61.
8. Santos DB, Moreira Jr ED, Abdo CHN, Wroclawski ER, Fittipaldi JAS. Epidemiologia da disfunção erétil no Brasil: resultados da pesquisa nacional do projeto avaliar. Rev Bras Med 2004(9):613-25.
9. Virag R, Bouilly P, Frydman D. Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet 1985;1:181-4.
10. Jensen J, Lendorf A, Stimpel H, Frost J, Ibsen H, Rosenkilde P. The prevalence and etiology of impotence in 101 male hypertensive outpatients. Am J Hypertens 1999;12:271-5.
11. Rosen MP, Greenfield AJ, Walker TG. Arteriogenic impotence: findings in 195 impotent men examined with selective internal pudendal angiography. Radiology 1990;174:1043-8.
12. Sasayama S, Ishii N, Ishikura F, et al. Men's Health Study. Epidemiology of erectile dysfunction and cardiovascular disease. Circulation J 2003;67:656-59.
13. Rosen RC, Cappetteri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999;11:319-26.
14. NIH Consensus Conference. Impotence: NIH Consensus Development Panel on impotence. JAMA 1993;270:83-90.
15. Benet AE, Melman A. The epidemiology of erectile dysfunction. Urol Clin North Am 1995;22:699-709